1. Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy. Issue 1 (26th August 2019) Authors: Zhang, Jinyu; Larrocha, Pablo Saenz-lopez; Zhang, Bin; Wainwright, Derek; Dhar, Payal; Wu, Jennifer D. Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BIOM-43. THE GENOMIC, TRANSCRIPTOMIC, AND EPIGENOMIC LANDSCAPE OF ISOCITRATE DEHYDROGENASE WILD TYPE GLIOBLASTOMA ACROSS THE AGE CONTINUUM. (14th November 2022) Authors: Johnson, Margaret; Bell, April; Shah, Yajas; Viets-Layng, Kayla; Mauer, Elizabeth; Xiu, Joanne; Elemento, Olivier; Glantz, Michael; Walker, Phillip; Chen, Clark; Dunbar, Erin; Fonkem, Ekokobe; Kesari, Santosh; Brenner, Andrew; Newton, Herbert; Low, Justin; Sumrall, Ashley; Korn, Wolfgang; Ashley,... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CBMT-34. MODULATING DIETARY TRYPTOPHAN OR GUT MICROBIOTA LEVELS DOES NOT IMPROVE THE EFFICACY OF COMBINED TREATMENT WITH RADIATION, ANTI-PD-1 mAb, AND AN IDO1 ENZYME INHIBITOR IN A MODEL OF GLIOBLASTOMA. (11th November 2019) Authors: Ladomersky, Erik; Zhai, Lijie; Lauing, Kristen; Qian, Jun; Bell, April; Otto-Meyer, Sebastian; Savoor, Rohan; Wainwright, Derek Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CNSC-27. AN IDO-PROTAC HIGHLIGHTS A NOVEL TRYPTOPHAN METABOLISM- INDEPENDENT ROLE FOR IMMUNOSUPPRESSIVE IDO IN HUMAN GLIOBLASTOMA. (14th November 2022) Authors: Bommi, Prashant; Monsen, Paige; Bommi, Lakshmi; Zhai, Lijie; Bell, April; Lauing, Kristen; Mi, Xinlei; Kocherginski, Masha; Horbinski, Craig; Lukas, Rimas; Schiltz, Gary; Wainwright, Derek Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTIM-12. A PHASE 1 TRIAL OF IMMUNORADIOTHERAPY WITH THE IDO ENZYME INHIBITOR (BMS-986205) AND NIVOLUMAB IN PATIENTS WITH NEWLY DIAGNOSED MGMT PROMOTER UNMETHYLATED IDHwt GLIOBLASTOMA. (12th November 2021) Authors: Lukas, Rimas; Sachdev, Sean; Kumthekar, Priya; Dixit, Karan; Grimm, Sean; Gondi, Vinai; Sharp, Laura; Lezon, Ray; James, David; Lesniak, Maciej; Stupp, Roger; Wainwright, Derek Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTIM-21. AN AGE-SPECIFIC BIOMARKER IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH RADIATION, NIVOLUMAB AND BMS-986205. (12th November 2021) Authors: Kim, Miri; Ladomersky, Erik; Zhai, Lijie; Bollu, Lakshmi; Bell, April; Lauing, Kristen; Rabin, Erik; Horbinski, Craig; Lukas, Rimas; Wainwright, Derek Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DDRE-09. DEVELOPING IDO-PROTACS TO IMPROVE IMMUNOTHERAPEUTIC EFFICACY IN PATIENTS WITH GLIOBLASTOMA. (9th November 2020) Authors: Bollu, Lakshmi; Wainwright, Derek; Zhai, Lijie; Ladomersky, Erik; Lauing, Kristen; Bell, April; Schlitz, Gary Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DDRE-11. SECOND GENERATION IDO INHIBITORS FOR IMPROVING IMMUNOTHERAPEUTIC EFFICACY IN PATIENTS WITH GLIOBLASTOMA. (12th November 2021) Authors: Bollu, Lakshmi; Bommi, Prashant; Wainwright, Derek; Ladomersky, Erik; Zhai, Lijie; Bell, April; Lauing, Kristen Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EPID-08. AGE-STRATIFIED SURVIVAL ANALYSES OF PHARMACOLOGICAL TREATMENTS IN PATIENTS WITH GLIOBLASTOMA. (14th November 2022) Authors: Rabin, Erik; Mi, Xinlei; Huang, Jonathan; Kim, Miri; Mozny, Andreas; Amidei, Christina; Sieg, Erica; Bell, April; Zhai, Lijie; Bommi, Prashant; Lauing, Kristen; Lukas, Rimas; Wainwright, Derek Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EPID-09. AGE-STRATIFIED SURVIVAL ANALYSES OF CO-MORBIDITIES IN PATIENTS WITH GRADE IV GLIOMAS. (14th November 2022) Authors: Rabin, Erik; Mi, Xinlei; Huang, Jonathan; Kim, Miri; Mozny, Andreas; Amidei, Christina; Sieg, Erica; Bell, April; Zhai, Lijie; Bommi, Prashant; Lauing, Kristen; Lukas, Rimas; Wainwright, Derek Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗